Healthcare analysts weighed in today with a favorable reports on biopharmaceutical giants Celgene Corporation (NASDAQ:CELG) and Biogen Inc (NASDAQ:BIIB), after the companies released their …
Healthcare analyst Eric Schmidt of Cowen & Co. reiterated an Outperform rating on Biogen Inc (NASDAQ:BIIB) today with a $368 price target, marking …
Relypsa Inc (NASDAQ:RLYP) is up nearly 6% to $29.40 in pre-market trading due to speculation that the company may be in M&A talks.
Analysts are weighing in on the pharmaceutical giant Gilead Sciences, Inc. (NASDA:GILD) and Cambridge biotechnology giant Biogen Inc (NASDAQ:BIIB), with mixed ratings and views.
We are fully into earnings season, and the battle continues. Last week, we had a number of big names report: some good, some …
Cowen and Co.’s Eric Schmidt covers several companies in the biotechnology sector.
On July 2 before market open, Biogen Inc (NASDAQ:BIIB) and Applied Genetic Technologies Corp (NASDAQ:AGTC) announced a broad collaboration and license agreement to …
Four men taking part in an illegal insider trading scheme between California, New Jersey, and Florida have been arrested and charged after earning …
On April 29, Joshua Schimmer of Piper Jaffray released a report highlighting several biopharmaceutical companies tackling Sickle Cell Disease, or SCD. The hereditary blood disorder …
In a research report released today, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on shares of Biogen Inc (NASDAQ:BIIB), but slightly reduced the …
